APO-ATAZANAVIR atazanavir 150 mg (as sulfate) capsule bottle

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

atazanavir sulfate, Quantity: 170.85 mg (Equivalent: atazanavir, Qty 150 mg)

Saatavilla:

Arrotex Pharmaceuticals Pty Ltd

Lääkemuoto:

Capsule

Koostumus:

Excipient Ingredients: magnesium stearate; sodium starch glycollate type A; purified water; hydrophobic colloidal silica anhydrous; lactose monohydrate; titanium dioxide; indigo carmine; Gelatin

Antoreitti:

Oral

Kpl paketissa:

60's

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

Atazanavir is indicated for the treatment of HIV 1 infection, in combination with other antiretroviral agents. ,This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts from controlled studies

Tuoteyhteenveto:

Visual Identification: Hard gelatin capsules with blue opaque cap and powdered-blue opaque body, imprinted APO on cap and A150 on body in black ink, filled with almost white granules; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Valtuutuksen tilan:

Registered

Valtuutus päivämäärä:

2018-05-14